Sino Land (0083)
Hong Kong Stock Exchange · Hong Kong · prices in HKD · close of 23 Oct 2026
Key indicators
| Last close | HKD 10.66 |
|---|---|
| 52-week range | 9.58 – 13.30 |
| Return, 1 month / 3 months | +4.3% / −2.0% |
| Return, 1 year / 3 years | +10.4% / +51.1% |
| Trend | Below its 200-day average |
| RSI (14) | 60 |
| Volatility (1 year) | 23.7% |
| Worst drawdown (1 year) | -25.2% |
| Average daily value traded | 86.73M HKD |
| Dividend yield | 5.4% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Sino Land is a property company based in Hong Kong. It develops residential estates and owns and manages investment properties, including shopping malls, offices and other commercial space, largely in Hong Kong. The company also has interests in hotels and car parking facilities. Its customers include home buyers, retail and office tenants, and hotel guests, and its activities centre on the Hong Kong property market, with some interests elsewhere in the region.
The shares are listed on the Hong Kong Stock Exchange in Hong Kong under the code 0083, and the price on this page is in Hong Kong dollars (HKD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Sino Land (0083) trades on the Hong Kong Stock Exchange in Hong Kong. It last closed at HKD 10.66 on 23 October 2026.
Its price-based Market X-Ray is 75 out of 100 (a strong price profile), ranking 209 of 2,613 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 10.4% and over the last three months it fell 2.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Hong Kong Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 66 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -4.7% | ||
| From 52-week high | -19.6% | ||
| Momentum | 61 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -2.0% | ||
| 6-month return | -14.9% | ||
| 12-month return, skipping the last month | 5.9% | ||
| Stability (higher is calmer) | 90 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 23.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -25.2% | ||
| Liquidity | 90 · Strong | Trades actively. | |
| Average daily value traded | 86.73M HKD | ||
| Zero-volume days | 0.0% | ||
| Income | 74 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 5.4% | ||
| Years with dividends | 6 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
- Income: Dividend is high and has been paid regularly.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +1.5% |
|---|---|
| 1 month | +4.3% |
| 3 months | −2.0% |
| 6 months | −14.9% |
| 1 year | +10.4% |
| 3 years | +51.1% |
| 5 years | +33.7% |
Signals
| 50-day / 200-day average | 10.33 / 11.18 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.22 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 12 Mar 2026 | HKD 0.1500 |
| 24 Oct 2025 | HKD 0.4300 |
| 11 Mar 2025 | HKD 0.1500 |
| 25 Oct 2024 | HKD 0.4300 |
| 6 Mar 2024 | HKD 0.1500 |
| 27 Oct 2023 | HKD 0.4300 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Hong Kong Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.